Category: Funding Opportunities

You may be interested in these recent funding opportunity announcements (FOAs):

Renewal of Centers of Biomedical Research Excellence (COBRE) (P20)
(PAR-13-243)

Purpose: Establish a thematic, multidisciplinary center and enhance the ability of investigators to compete independently for NIH or other external peer-reviewed support
Application due dates: September 25, 2013; September 25, 2014; September 25, 2015
NIGMS contact: Yanping Liu, 301-451-4217

Limited Competition: Centers of Biomedical Research Excellence (COBRE) Phase III — Transitional Centers (P30)
(PAR-13-238)

Purpose: Strengthen phase I COBRE centers through improvements in research infrastructure as well as the development and support of investigators
Application due date: August 2, 2013
NIGMS contact: J. Rafael Gorospe, 301-435-0832

Native American Research Centers for Health (NARCH) (S06)
(PAR-13-239)

Purpose: Conduct research and research training to meet the needs of American Indian/Alaska Native communities
Letter of intent due date: July 6, 2013
Application due date: August 6, 2013
NIGMS contact: Sheila A. Caldwell, 301-594-3900

Reissue PHS 2013-02 Omnibus Solicitation of the NIH, CDC, FDA and ACF for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44])
(PA-13-234)

Purpose: Research and develop innovative technologies with commercial applications*
Application due date: Standard dates apply
NIGMS contact: Scott Somers, 301-594-3827

Reissue PHS 2013-02 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42])
(PA-13-235)

Purpose: Research and develop innovative technologies with commercial applications*
Application due date: Standard dates apply
NIGMS contact: Scott Somers, 301-594-3827

*There are important changes in the reissued SBIR/STTR FOAs, including: 1) Majority venture-capital owned companies are now eligible to apply for the NIH SBIR program; 2) All small business concerns must now register with the SBA Company Registry; and 3) NIGMS will not accept applications to the new SBIR/STTR FOAs that exceed the hard cap ($225,000 total cost for Phase I applications and $1,500,000 for Phase II applications). For more information, see the NIH SBIR/STTR Web site.

You may be interested in these recent funding opportunity announcements:

Improvement of Animal Models and Development of Technologies for Stem Cell-Based Regenerative Medicine (SBIR)(R43/R44)
(PA-13-223)

Purpose: Develop or improve animal models and/or technologies for obtaining, characterizing and testing animal and human stem cells and their derivatives for regenerative medicine
Application due date: Standard dates apply
NIGMS contact: Stefan Maas, 301-594-0943

Improvement of Animal Models and Development of Technologies for Stem Cell-Based Regenerative Medicine (STTR)(R41/R42)
(PA-13-224)

Purpose: Develop or improve animal models and/or technologies for obtaining, characterizing and testing animal and human stem cells and their derivatives  for  regenerative medicine
Application due date: Standard dates apply
NIGMS contact: Stefan Maas, 301-594-0943

Short Courses on Innovative Methodologies in the Behavioral and Social Sciences (R25)
(RFA-OD-13-009)

Purpose: Develop, implement, evaluate and disseminate short courses in innovative methods for behavioral and social sciences research
Letter of intent due date: June 3, 2013
Application due date: July 3, 2013
NIGMS contact: Stephen Marcus, 301-451-6446

NIH has released two funding opportunity announcements to help restore facilities and/or research programs that were significantly disrupted by Hurricane Sandy last fall:

RFA-OD-13-199: Administrative supplements to awards that were active at the time of the storm

RFA-OD-13-005: Grants to new and early stage investigators whose pilot research and data were destroyed or damaged as a result of the storm

Eligibility is restricted to FEMA-declared major disaster states, and funds are limited to those made available by the Disaster Relief Appropriations Act of 2013. As discussed in a blog post from NIH’s Sally Rockey, NIH anticipates announcing additional opportunities and resources related to the Hurricane Sandy recovery effort.

You may be interested in this recent funding opportunity announcement from the NIH Common Fund that NIGMS will administer:

Undiagnosed Diseases Gene Function Research (R21)
(RFA-RM-13-003)

Purpose: Investigate the underlying genetics, biochemistry and/or pathophysiology of newly diagnosed diseases in association with the respective gene variant(s) identified through the NIH Undiagnosed Diseases Network
Letter of intent due date: May 14, 2013
Application due date: June 14, 2013
NIGMS contact: Donna Krasnewich, 301-594-0943

You may be interested in these recent funding opportunity announcements:

Limited Competition: Revision Applications for Basic Social and Behavioral Research on the Social, Cultural, Biological, and Psychological Mechanisms of Stigma (R01)
(RFA-MD-13-005)

Purpose: Revise applications to incorporate basic research on behavioral and social mechanisms underlying stigma into active R01 research projects
Letter of intent due date: July 2, 2013
Application due date: August 2, 2013
NIH contacts:
Jennifer Alvidrez, NIMHD, 301-594-9567
Rebecca Ferrer, NCI, 301-594-0437
Enid Light, NIMH, 301-443-3599
Kathleen Michels, FIC, 301-435-6031

Development of Highly Innovative Tools and Technology for Analysis of Single Cells (SBIR) (R43/R44)
(PA-13-140)

Purpose: Develop next-generation tools that distinguish heterogeneous states among cells and have commercial potential
Application due date: Standard dates apply
NIGMS contact: Stefan Maas, 301-594-0943

Last September, I described a concept clearance for an initiative to develop new approaches in natural products discovery that had just been approved by the NIGMS Advisory Council. The resulting request for applications on Genomes to Natural Products (U01) has now been published in the NIH Guide.

NIGMS, along with the National Center for Complementary and Alternative Medicine (NCCAM), will support multidisciplinary research to develop high-throughput, broadly applicable approaches to natural products discovery that integrate genomics, synthetic biology and bioinformatics. We anticipate that up to four awards will be made through the cooperative agreement mechanism, totaling up to $9 million in Fiscal Year 2014. For NCCAM-specific interest areas and application requirements, see NOT-AT-13-005.

Applications are due by July 17. Potential applicants are invited to participate in an optional online Q&A session on April 19 from 1 p.m. to 3 p.m. EDT. Access this event at https://webmeeting.nih.gov/rfa-gnpn/ and sign in as a “guest” to be able to submit questions.

Letters of intent are not needed, but depending on which funding component’s areas of interest are more relevant to the proposal, I strongly recommend that potential applicants e-mail me or my counterpart at NCCAM, Craig Hopp to discuss submission plans.

You may be interested in these recent funding opportunity announcements:

These two announcements are based on a broader initiative for research on macromolecular interactions in cells in vivo. The initiative also includes an additional funding opportunity, Revisions for Macromolecular Interactions in Cells (R01).

• Collaborations for Macromolecular Interactions in Cells (R01)
  (RFA-GM-14-004)

Purpose: Establish interdisciplinary collaborative projects to advance studies of macromolecular interactions and their relationship to function in cells, tissues and organisms

• Research Networks for Macromolecular Interactions in Cells (U54)
  (RFA-GM-14-005)

Purpose: Establish interdisciplinary collaborative research networks to advance studies of macromolecular interactions and their relationship to function in cells, tissues and organisms

Letter of intent due date: April 30, 2013
Application due date: May 30, 2013
NIGMS contacts:
Alexandra Ainsztein, 301-594-0828
Daniel Janes, 301-594-0943
Vernon Anderson, 301-594-3827
Paul Brazhnik, 301-451-6446

Bioengineering Research Grants (BRG) (R01)
(PAR-13-137)

Purpose: Develop an innovative technology, model, technique, design or method that infuses principles and concepts from the quantitative sciences to increase our understanding of and solve problems in biological, clinical or translational science
Application due date: Standard dates apply
NIGMS contact: Pamela Marino, 301-594-3827

In addition, several new NIH Common Fund funding opportunities related to workforce development and diversity are listed at http://commonfund.nih.gov

You may be interested in these recent funding opportunity announcements:

Mechanisms, Models, Measurement, and Management in Pain Research (R01)
(PA-13-118)

Purpose: Conduct basic, clinical and translational studies on pain related to the missions of the participating NIH institutes and center
Application due dates: Standard dates apply
NIGMS contact: Alison Cole, 301-594-3827

Improvement of Animal Models for Stem Cell-Based Regenerative Medicine (R01)
(PAR-13-114)

Purpose: Propose research aimed at characterizing animal stem cells as well as improving and/or creating animal models for human disease conditions (see announcement for information on NIGMS-specific interests)
Application due dates: Standard dates apply
NIGMS contact: Susan Haynes, 301-594-0943